Beximco Pharma starts production of Merck’s COVID pill
Beximco Pharmaceuticals has launched production of the generic version of US drugmaker Merck & Co’s experimental pill to treat COVID-19. The company officially launched production of the oral antiviral drug molnupiravir, for symptomatic COVID-19 on Tuesday, after receiving the...